复合N-乙酰半胱氨酸丝素蛋白磷酸钙骨水泥的理化性能及细胞毒性

BACKGROUND: Calcium phosphate cements (CPCs) possess the bio-degradation and osteoconduction, and its final hydration product, hydroxyapatite, is the main inorganic constituent of bones. However, its poor mechanical property makes it unable to be used for repairing weight-bearing bone defects. OBJECTIVE: To develop a kind of bioactive bone cements with decent biomechanical property and biocompatibility. METHODS: 6% silk fibroin aqueous solutions containing different concentrations of N-acetylcysteine (0, 10 and 25 mmol/L) were prepared. Each cement sample was prepared by mixing the curing liquid and α-tricalcium phosphate powder with the ratio of 0.4 mL: 1 g; α-tricalcium phosphate powder mixed with ddH2O as control group. The compressive strength, setting time of the cements were measured. The crystal components of the cements were characterized using X-ray diffraction and the microstructure was observed using scanning electron microscope. MC3T3-E1 cells were seeded onto the material in each group, and cell morphology was observed under scanning electron microscope at 24 hours. MC3T3-E1 cells were cultured in the extract of each material, cell proliferation was detected at 1, 3, 5 and 7 days, and the lactate dehydrogenase level was detected at 1 and 3 days. RESULTS AND CONCLUSION: X-ray diffraction and scanning electron microscope showed that the final hydration products of α-tricalcium phosphate in all specimens were hydroxyapatite. When the concentration of N-acetylcysteine was 25 mmol/L, the compressive strength of the material reached (49.39±1.68) MPa, with the initial setting time of (21.77±1.07) minutes and the final setting time of (31.88±1.69) minutes. There was no significant difference in cell morphology among cements. These results suggest that the cement containing N-acetylcysteine exhibites good biocompatibility and high mechanical strength.     

多孔磷酸钙骨水泥/纤维蛋白胶性状及对成骨细胞生物学行为的影响CSCD

背景:在多孔材料磷酸钙骨水泥粉末中复合纤维蛋白胶是否能有效改善磷酸钙骨水泥的生物力学性能,同时加速其在体内的降解代谢,促进体内骨再生,目前还未被证实。目的:构建不同配比的多孔磷酸钙骨水泥/纤维蛋白胶复合材料,探索其诱导成骨的生物学特性。方法:将磷酸钙骨水泥与纤维蛋白胶分别以1∶1、3∶1、5∶1(mL/g)的配比复合,以单纯的磷酸钙骨水泥为对照,检测各组材料的初凝和终凝时间、压缩强度与弹性模量,扫描电镜观察材料表面结构。将第3代成骨细胞分别接种于4组材料表面,以单纯培养细胞为空白对照,观察不同时间点细胞黏附、增殖及碱性磷酸酶活性。结果与结论:1∶1、3∶1复合材料组初凝时间和终凝时间长于对照组(P<0.05),5∶1组复合材料组初凝时间和终凝时间短于对照组(P<0.05)。磷酸钙骨水泥/纤维蛋白胶复合材料表面较单纯的磷酸钙骨水泥致密而光滑,孔径随着纤维蛋白胶浓度的增加而降低。3∶1、5∶1复合材料组压缩强度高于对照组(P<0.05),1∶1、3∶1、5∶1复合材料组弹性模量高于对照组(P<0.05)。4组材料上的细胞黏附、增殖及碱性磷酸酶活性差异无显著性意义,但均高于空白对照组(P<0.05)。表明纤维蛋白胶的加入克服了磷酸钙骨水泥脆性较高的缺点,同时也保留了其促进成骨的作用。     

MC3T3-E1细胞成骨模型的应用及研究进展

骨形成与骨重建涉及各种细胞的协同作用。通过各种体外培养模型,在了解成骨过程的生物学方面取得了显著进展。当前,骨组织工程研究火热,但由于原代人成骨细胞十分有限,这些细胞模型越来越多地被应用。MC3T3-E1细胞是前骨细胞,该细胞在研究骨骼疾病和骨缺损的细胞治疗及组织工程方面具有较大潜力。本文全面回顾了MC3T3-E1细胞成骨模型的培养、鉴定及应用等方面内容。此外,还进一步讨论了该模型的优缺点并提出了几点展望。     

N-乙酰半胱氨酸丝素微球复合磷酸钙骨水泥的制备及表征

BACKGROUND: Calcium phosphate bone cement has been applied to clinical surgery because of its good biocompatibility and osteoconduction. However poor mechanical properties and lack of osteoinductivity limit its wide application. OBJECTIVE: To develop calcium phosphate cement incorporated with N-acetylcysteine (NAC) loaded silk fibroin microspheres (SFM), which is a kind of new injectable bone graft material with slow-release function, and evaluate its physical and chemical properties and cell compatibility. METHODS: Empty SFMs were prepared with emulsion solvent evaporation to absorb NAC solution of different concentrations by NAC-SFM and the concentration of NAC at the maximum drug loading ratio was determined. Then, NAC-SFM was loaded into calcium phosphate bone cement to test the drug release properties in vitro. MC3T3-E1 osteoblasts were cultured on the surface of NAC-SFM calcium phosphate bone cement and cell attachment and growth were observed by scanning electron microscope. Additionally, MC3T3-E1 cells were cultured with three kinds of bone cement extracts (calcium phosphate cement, SFM-calcium phosphate cement, NAC-SFM-calcium phosphate cement, as well as cultured in the α-minimum essential medium containing a volume fraction of 10% fetal bovine serum and 1% penicillin-streptomycin double antibody as the control. MTS assay was used to evaluate cell proliferation. RESULTS AND CONCLUSION: Microspheres in the composite bone cement presented with smooth surface, same size, diffused distribution and no obvious destroy. Thus, the SFM could remain stable in the reaction process of the composite bone cement. The double slow release system which contained silk fibroin microspheres and calcium phosphate bone cement showed a significant decrease in the cumulative release percentage of NAC within the first 24 hours compared with the control group (P < 0.05). In the next 28 days, the release speed of NAC was significantly lower in the NAC-SFM-calcium phosphate cement group than the calcium phosphate cement group (P < 0.05). In addition, different extracts had no significant cytotoxicity to the growth of MC3TC-E1 cells. Thus, the NAC-SFM-calcium phosphate cement has good cytocompatibility, which provide a new insight into the development of bone repair biomaterials. 中国组织工程研究杂志出版内容重点：生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程     

β-蜕皮甾酮促进小鼠前成骨细胞体外增殖及诱导成骨分化

文题释义：β-蜕皮甾酮：又称蜕皮激素、20-羟基蜕皮甾酮,分子式C₂₇H₄₄O₇,为黄棕色至白色粉末,味苦;主要存在于昆虫、蚕、露水草、牛膝、川牛膝等动植物体内,具有调节血糖血脂、促进胶原蛋白合成、抗疲劳、促进细胞生长和刺激真皮细胞分裂等作用,目前广泛应用于化妆品、医疗以及养殖业等领域。骨形态发生蛋白质2：是从脊椎动物骨骼基质中分离提纯的蛋白质,具有内肽酶活性、表皮生长因子模体,同源二聚体之间以二硫键相连,属于转化生长因子β家族,能诱导骨与软骨形成。骨桥蛋白：存在于矿化和活性沉积区,是一种含有Arg-Gly-Asp(RGD)结构的酸性糖蛋白,它与诱导成骨细胞成熟表型表达和矿化骨基质形成的活性蛋白密切相关。在成矿阶段,骨连接素、纤连蛋白与骨桥蛋白的表达高度相关。Ⅰ型胶原是钙盐沉积和细胞附着的支架,可促进细胞附着并刺激细胞分化。背景：β-蜕皮甾酮作为“植物类雌激素”不仅具有刺激蛋白质合成,促进碳水化合物和脂质代谢,缓解高血糖、高脂血症,以及保护内皮细胞免于凋亡并诱导其增殖的多种生物活性,而且有学者报道其在治疗骨质疏松症、骨折和其他骨骼炎症性疾病方面也有着重要的作用。 目的：观察β-蜕皮甾酮对小鼠前成骨细胞(MC3T3-E1细胞)体外增殖的影响,以及在安全剂量下,β-蜕皮甾酮是否对该细胞具有诱导成骨分化的作用。方法：取第4代MC3T3-E1细胞在成骨诱导分化培养基中培养7,10,14,21,28 d后,检测细胞不同时间段成骨分化蛋白(碱性磷酸酶、Ⅰ型胶原蛋白、骨桥蛋白以及钙化结节)的表达量,以鉴定该细胞是否具有成骨分化的能力;然后将MC3T3-E1细胞接种于含不同终浓度β-蜕皮甾酮(0.01,0.1,1,10,100 µmol/L)的诱导培养基中,分别于第1,2,3,4,5,6,7天利用CCK8法检测细胞的增殖活性;最后设置对照组(普通诱导培养基组)和实验组(普通诱导培养基+β-蜕皮甾酮),在相同条件下进行培养,并测定不同时间段各组细胞成骨标志蛋白的表达量。结果与结论：①MC3T3-E1细胞在成骨诱导培养基刺激下,第10天碱性磷酸酶染色以及Ⅰ型胶原蛋白荧光染色表达较高,同时碱性磷酸酶活性检测也验证了这一结果(P < 0.05);诱导培养第14天骨桥蛋白免疫细胞化学染色也有明显表达;茜红素染色显示成骨诱导后的细胞较对照组结节数量明显增加,第28天比第21天的钙结节形成数目更多、直径更大、颜色更深;②CCK 8法测得β-蜕皮甾酮对MC3T3-E1细胞作用5 d后增殖活性达到最佳,促增殖活性最佳剂量为0.01 µ mol/L、0.1 µmol/L,2种浓度之间差异无显著性意义(P > 0.05);③实验组细胞经β-蜕皮甾酮诱导培养第10天较对照组细胞碱性磷酸酶、Ⅰ型胶原蛋白表达更高;第14天实验组细胞内骨桥蛋白、骨钙素表达更高;第28天2组钙结节染色无明显差异;④结果说明,β-蜕皮甾酮能促进MC3T3-E1细胞体外增殖,且在安全剂量下能提高MC3T3-E1细胞向成骨细胞分化的能力。ORCID: 0000-0001-5641-6353(严才平) 中国组织工程研究杂志出版内容重点：组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松;组织工程     

磷酸钙骨水泥承载头孢哌酮钠后对其理化特性的影响

分析不同复合比例的头孢哌酮钠 磷酸钙骨水泥复合体的理化特性。其方法为制备含头孢哌酮钠与磷酸钙骨水泥质量比分别为 0 %、2 9%、4 8%、7 4%的复合材料 ,观察固化时间 ,用材料万能试验机测试抗压极限强度 ,用扫描电镜观察和分析超微结构等。结果表明 :磷酸钙骨水泥承载头孢哌酮钠后 ,随着所承载药物量的增加 ,固化时间和孔隙率的变化不显著 ;而抗压极限强度逐渐降低 ,四组抗压极限强度分别为 2 1 98± 1 0 6、2 1 38± 0 95、19 2 2± 1 11、13 5± 1 6 5MPa。磷酸钙骨水泥承载头孢哌酮钠药量在 0 % 4 8%之间对其理化特性无显著影响 ,复合体存在自然孔隙 ,具有较强的抗压性能 ,有望成为感染性骨缺损的理想修复材料。     

复合型磷酸钙骨水泥及其外加剂的研究进展

磷酸钙骨水泥(CPC)经过10多年的研究,取得了很大的进展。而外加剂以及复合物对CPC的性能有着重要的影响,它们的研究同CPC相比还处于起步阶段。本文综术了CPC的复合物及其外加剂最新研究结果,包括纤维及交联剂增强CPC,CPC抗水剂、促凝剂和增塑剂的研究,有机复合CPC骨水泥的研究,同生长因子复合CPC和载药CPC等。     

锌修饰硅酸钙陶瓷涂层与骨整合

BACKGROUND: Zinc-modified calcium silicate (CaSiO3) bioceramics coating on the titanium surface prepared in preliminary experiments has good chemical stability and antibacterial property. OBJECTIVE: To observe the effects of zinc-modified CaSiO3 bioceramics coating on osteointegration. METHODS: MC3T3-E1 cells were respectively cultured on the titanium with zinc-modified CaSiO3 bioceramics coating (experiment group), titanium with CaSiO3 bioceramics coating (control group) and pure titanium (blank control group). Then, cell adhesion, proliferation, calcification rate and the expression of type I collagen and osteocalcin were detected. The implant materials mentioned above were respectively inserted into the femurs of New Zealand white rabbits, and after 1.5 months, the osteoproliferation and osteointegration between the implants and the host were tested. RESULTS AND CONCLUSION: In vitro experiment: The number of adhesive cells at 12 hours after co-culture was significantly increased in the experimental group compared with the control group and blank control group (P < 0.05). At 14 days after co-culture, cell proliferation ability and ability of calcium nodule formation in the experiment group were significantly better than those in the other groups (P < 0.05). At 21 days after co-culture, there was no significant difference in the expression of type I collagen, but the expression of osteocalcin in the experiment group was higher than that in the control group and blank control group (P < 0.05). In vivo experiment: In the experiment group, a large amount of bone substances were detected, the coating materials directly contacted with the bone interface, new bone tissues and little fibrous tissues were observed at the interface. In contrast, there was a small amount of bone hyperplasia in the control group and almost no bone hyperplase in the blank control group. Moreover, a small part of the implant directly contacted with the bone interface and the most part was separated from bone trabeculae by fibrous tissues. These findings indicate that zinc-modified CaSiO3 bioceramics coating can enhance the ability of osteointegration between titanium implants and the host.      

医用磷酸钙骨水泥的制备及性能的实验研究

探索了磷酸四钙（Ca4（PO4）2O，TTCP）的制备，并合成了磷酸钙骨水泥（CPC），对CPC固化时间、引起浸泡液pH值的变化、抗压强度、产物物相组成及微观结构进行了研究。结果表明：在真空条件下、1500℃下煅烧6h可制得TTCP，并含有少量CaO。CPC初凝时间为4min、终凝时间为15min，浸泡1d和7d后的抗压强度分别为20MPa和35MPa，浸泡液的pH值在6．4～8．9之间变化，这些性能均符合临床用CPC的性能要求。CPC水化产物为片状或针状羟基磷灰石（Ca5（PO4）3OH，HA），相互交错呈连续分布的网状结构，这种结构有利于材料强度的提高。实验研制的CPC材料可用于骨缺损的修复治疗。     

复合唑来膦酸磷酸钙骨水泥的力学性能测定

目的研究加入不同浓度的唑来膦酸对磷酸钙骨水泥体外凝结时间、抗压强度的影响。方法将唑来膦酸与磷酸钙骨水泥以不同质量比混合,制备力学性能测试标本,并分为A(空白对照)、B(含0.2%唑来膦酸)、C(含0.4%唑来膦酸)、D(含0.6%唑来膦酸)4组,每组6个标本。测定其凝结时间及抗压强度。结果随载药浓度的增加,复合磷酸钙骨水泥凝结时间逐渐延长,但各实验组凝结时间与空白对照组均无明显统计学差异(0.05)。B、C组抗压强度与A组之间无明显统计学差异(0.05),而D组与A组之间有统计学差异(=0.000)。结论三组中唑来膦酸的添加量对磷酸钙骨水泥凝结时间无明显影响,且各组凝结时间均满足临床应用标准。含0.2%和0.4%唑来膦酸对磷酸钙骨水泥抗压强度无明显影响,而含0.6%唑来膦酸可使磷酸钙骨水泥抗压强度明显降低。但三含量组的抗压强度均满足临床应用标准。     

The physicochemical properties of the solidification of calcium phosphate cement

In this article, the physicochemical properties of the solidification of calcium phosphate cement (CPC) were investigated, and the components of the solidified body and the characteristics involved in the application were measured. The setting process of CPC was moderate and slightly exothermic, the heat liberation rate was slow, and the temperature increased little. At the initial stage of the hydration, the compressive strength rose linearly with time, and reached the maximum value after 4 hours. The volume was slightly shrunken by 1% during the setting process, and the total heavy metal content was below 2 ppm. The porosity of the solidified body was about 30%, which was mainly the gel pore with size below 0.1 microm. The final product of hydration was low crystalline hydroxyapatite (HAP). Its real density was 2.859 g/cm(3), which was lower than the theoretical value. This may be due to the existence of lattice defects, which will lead to a slight rise in solubility when leached in physiological saline.     

The cytocompatibility and early osteogenic characteristics of an injectable calcium phosphate cement

In this study, the cytocompatibility and early osteogenic characteristics of rat bone marrow cells (RBMCs) on injectable calcium phosphate (CaP) cement (Calcibon) were investigated. In addition to unmodified CaP cement discs, 2 other treatments were given to the discs: preincubation in MilliQ and sintering at different temperatures. After primary culture, RBMCs were dropwise seeded on the discs and cultured for 12 days. The samples were evaluated in terms of cell viability, morphology (live and dead assays and scanning electron microscopy (SEM)), cell proliferation (deoxyribonucleic acid (DNA) analyses), early cell differentiation (alkaline phosphatase (ALP) activity), and physicochemical analyses (x-ray diffraction (XRD)). The live and dead, DNA, and SEM results showed that Calcibon discs without any additional treatment were not supporting osteoblast-like cells in vitro. There were fewer cells, and cell layers were detached from the disc surface. Therefore, different preincubation periods and sintering temperatures were evaluated to improve the cytocompatibility of the CaP cement. Preincubating discs in MilliQ for periods of 1, 4, 8, and 12 weeks resulted in the hydrolysis of alpha-tri calcium phosphate (TCP) into an apatite-like structure with some beta-TCP, as shown with XRD, but the material was not cytocompatible. Sintering the discs between 800 degrees C and 1100 degrees C resulted in conversion of alpha-TCP to beta-TCP with some hydroxyapatite and an increase in crystallinity. Eventually, the discs sintered at 1100 degrees C achieved better cell attachment, more-abundant cell proliferation, and earlier differentiation than other sintered (600 degrees C, 800 degrees C, and 1000 degrees C), preincubated, and unmodified specimens. On basis of our results, we conclude that in vivo results with CaP-based cements do not guarantee in vitro applicability. Furthermore, unmodified Calcibon is not cytocompatible in vitro, although preincubation of the material results in a more-favorable cell response, sintering of the material at 1100 degrees C results in the best osteogenic properties. In contrast to in vivo studies, the Calcibon CaP cement is not suitable as a scaffold for cell-based tissue-engineering strategies.     

Transforming growth factor-beta1 incorporation in an alpha-tricalcium phosphate/dicalcium phosphate dihydrate/tetracalcium phosphate monoxide cement: release characteristics and physicochemical properties.

The osteoconductive properties of calcium phosphate cements (CPCs) may be improved by the addition of growth factors, such as recombinant human transforming growth factor-beta1 (rhTGF-beta1). Previously we have shown that rhTGF-beta1 was released from cement enriched with rhTGF-beta1 and subsequently stimulated the differentiation of pre-osteoblastic cells from adult rat long bones. It is unknown whether the addition of rhTGF-beta1 changes the material properties of this alpha-tricalcium-phosphate (alpha-TCP)/tetracalcium-phosphate-monoxide (TeCP)/dicalcium-phosphate-dihydrate (DCPD) cement, and what the characteristics of the release of rhTGF-beta1 from this CPC are. Therefore, in the present study we determined the release of rhTGF-beta1 from cement pellets in vitro. The possible intervening effects of the CPC modification for intermixing rhTGF-beta1 on physicochemical properties were studied by assessing the compressive strength and setting time, as well as crystallinity, calcium to phosphorus ratio, porosity and microscopic structure. Most of the previously incorporated rhTGF-beta1 in the cement pellets was released within the first 48 h. For all concentrations of rhTGF-beta1 intermixed (100 ng-2.5 mg/g CPC), approximately 0.5% of the amount of rhTGF-beta1 incorporated initially was released in the first 2 h, increasing to 1.0% after 48 h. The release of rhTGF-beta1 continued hereafter at a rate of about 0.1% up to 1 week, after which no additional release was found. The initial setting time, nor the final setting time was changed in control cement without rhTGF-beta1 (standard CPC) or in cement modified for rhTGF-beta1 (modified CPC) at 20 degrees C and 37 degrees C. Setting times were more than six times decreased at 37 degrees C compared to 20 degrees C. The compressive strength was initially low for both standard CPC and modified CPC, after which it increased between 24 h and 8 weeks. The compressive strength for the modified CPC was significantly higher compared with standard at 1, 2, and 8 weeks after mixing. X-ray diffraction revealed that both standard and modified CPC changed similarly from the original components into crystalline apatite. The calcium to phosphorus ratio as determined by an electron microprobe did not differ at all time points measured for standard CPC and modified CPC. In both standard CPC and modified CPC the separated particles became connected by crystals, forming a structure in which the particles could hardly be recognised in a densifying matrix with some small pores. The present study shows that the calcium phosphate cement is not severely changed by modification for the addition of rhTGF-beta1. The addition of rhTGF-beta1 in CPC enhances the biologic response as shown in our previous study and did not interfere with the aimed physical and chemical properties as shown in this study. We conclude that the addition of rhTGF-beta1 enlarges the potential of the CPC in bone replacement therapy.     

壳聚糖对纳米碳管／磷酸钙骨水泥性能的影响

通过不同添加方式将壳聚糖与纳米碳管／磷酸钙骨水泥混合，研究壳聚糖对复合材料性能的影响。结果表明：壳聚糖与复合粉体充分混合后，再加入去离子水时，可以更好提高复合材料的弯曲强度，壳聚糖含量为0．5％时可以得到较短的凝固时间和较高的弯曲强度（12．99MPa）。     

Dental composites based on amorphous calcium phosphate - resin composition/physicochemical properties study

This study explores how the resin composition/structure affects the physicochemical properties of copolymers and their amorphous calcium phosphate (ACP)-filled composites. A series of photo-polymerizable binary and ternary matrices are formulated utilizing 2,2-bis[ p-(2(')-hydroxy-3(')methacryloxypropoxy)phenyl]propane, 2,2-bis[ p-(2(')-methacryloxypropoxy)phenyl]-propane (EBPADMA), or a urethane dimethacrylate as base monomers, and triethylene glycol dimethacrylate or hexamethylene dimethacrylate (HmDMA) with or without 2-hydroxyethyl methacrylate (HEMA) as diluent monomer. Unfilled copolymers and composites filled with 40% by mass zirconia-hybridized ACP are evaluated for biaxial flexure strength (BFS), degree of conversion (DC), mineral ion release, polymerization shrinkage (PS), and water sorption (WS). The average DC values are 82-94% and 74-91% for copolymers and composites, respectively. Unrelated to the resin composition, the PS values of composites are up to 8.4 vol. % and the BFS values of wet composite specimens are on average 51 +/- 8 MPa. The maximum WS values attained in copolymers and composites reach 4.8 mass%. Inclusion of hydrophobic HmDMA monomer in the matrices significantly reduces the WS. The levels of Ca and PO(4) released from all types of composites are significantly above the minimum necessary for the re-deposition of apatite to occur. Elevated Ca, and to a lesser extent PO(4) release, is observed in HEMA-containing, ternary EBPADMA formulations. Further resin reformulations may be needed to improve the PS of composite specimens. Poor dispersion of ;as-synthesized' ACP within the composite contributes to their inferior mechanical performance.     

Effect of the calcium to phosphate ratio of tetracalcium phosphate on the properties of calcium phosphate bone cement

Six different tetracalcium phosphate (TTCP) products were synthesized by solid state reaction at high temperature by varying the overall calcium to phosphate ratio of the synthesis mixture. The objective was to evaluate the effect of the calcium to phosphate ratio on a TTCP-dicalcium phosphate dihydrate (DCPD) cement. The resulting six TTCP-DCPD cement mixtures were characterized using X-ray diffraction analysis, scanning electron microscopy, and pH measurements. Setting times and compressive strength (CS) were also measured. Using the TTCP product with a Ca/P ratio of 2.0 resulted in low strength values (25.61 MPa) when distilled water was used as the setting liquid, even though conversion to hydroxyapatite was not prevented, as confirmed by X-ray diffraction. The suspected CaO presence in this TTCP may have affected the cohesiveness of the cement mixture but not the cement setting reaction, however no direct evidence of CaO presence was found. Lower Ca/P ratio products yielded cements with CS values ranging from 46.7 MPa for Ca/P ratio of 1.90 to 38.32 MPa for Ca/P ratio of 1.85. When a dilute sodium phosphate solution was used as the setting liquid, CS values were 15.3% lower than those obtained with water as the setting liquid. Setting times ranged from 18 to 22 min when water was the cement liquid and from 7 to 8 min when sodium phosphate solution was used, and the calcium to phosphate ratio did not have a marked effect on this property.     

载药型磷酸钙骨水泥的制备及体外释放性能

背景：磷酸钙骨水泥具有良好的生物相容性,可作为骨修复材料与药物载体。 目的：制备载药磷酸三钙骨水泥,并分析其体外释放性能。 方法：采用共沉淀法制备磷酸三钙前躯体,经高温煅烧研磨获得α-磷酸三钙粉体,测试含不同浓度(1.25%,2.5%,3.75%,5%)抗生素(头孢拉定或头孢氨苄或环丙沙星)骨水泥,浸泡不同时间后(6 h、12 h、24 h、2 d、3 d、4 d、 5 d、6 d、7 d、8 d)的药物体外释放浓度。 结果与结论：制备的磷酸三钙粉体粒度约2 μm,结晶度良好。载不同抗生素的骨水泥体外释放都受自身物理性质的影响。载药骨水泥中环丙沙星能够满足长时间缓释,并能达到一个比较理想的缓释浓度,头孢类药物由于自身稳定性等原因,缓释效果并不理想。头孢氨苄的水解速率较低,环丙沙星的光降解条件比较苛刻,因此两者释放未受太大影响,与Higuchi模型基本吻合;头孢拉定的水解速率相对较高,对体系的释放驱动力产生较大影响,使得释放不再遵循Higuchi模型。     

Synthesis of a novel b-tricalcium phosphate/hydroxyapatite biphasic calcium phosphate containing niobium ions and evaluation of its osteogenic properties

To promote the osteogenic properties of osteoblasts, we synthesized a hydroxyapatite (HAp) with β-tricalcium phosphate (β-TCP) biphasic calcium phosphate containing Nb ions (NbTCP/HAp). NbTCP/HAp was prepared by annealing precipitates obtained by coprecipitation of an aqueous solution of Ca(NO₃)₂ and a mixture of (NH₄)₂HPO₄ and aqueous Nb solution. The precipitates can be regarded as a calcium-deficient HAp, the PO₄ sites of which are partly occupied by Nb ions. NbTCP/HAp was successfully synthesized by thermal decomposition of the precipitates. NbTCP/HAp enhanced the calcification of normal human osteoblasts (NHOst), and the amount of calcified tissue increased in proportion to the Nb ion concentration in the NbTCP/HAp. The alkaline phosphatase (ALP) activity of NHOst was also enhanced by NbTCP/HAp. Because Nb ions significantly enhance the ALP activity of NHOst, calcification by NbTCP/HAp is considered to be due to enhancement of ALP activity induced by Nb ions dissolved from NbTCP/HAp. These results indicate that NbTCP/HAp can be an effective bone repair material.     

Self-setting properties of a beta-dicalcium silicate reinforced calcium phosphate cement

Beta-dicalcium silicate was used to reinforce the injectable calcium phosphate cement (iCPC) for the first time in this study. The influence of the content of beta-dicalcium silicate on the mechanical properties, setting time, rheological properties, injectability, phase evolution, microstructure, and biodegradability of iCPC was systematically investigated. The results demonstrated that the addition of 8 wt % beta-dicalcium silicate obviously enhanced the compressive strength of the CPC from 26.5 to 47.5 MPa, and did not significantly influence the biodegradability, setting time, injectability, phase evolution, and microstructure of the CPC. The beta-dicalcium silicate-reinforced iCPC with relatively high mechanical property should have potential prospects for the wider applications in surgery such as orthopedics, oral, and maxillofacial surgery.     

Rheological properties of concentrated aqueous injectable calcium phosphate cement slurry

In this paper, the steady and dynamic rheological properties of concentrated aqueous injectable calcium phosphate cement (CPC) slurry were investigated. The results indicate that the concentrated aqueous injectable CPC showed both plastic and thixotropic behavior. As the setting process progressed, the yield stress of CPC slurry was raised, the area of the thixotropic hysteresis loop was enlarged, indicating that the strength of the net structure of the slurry had increased. The results of dynamic rheological behavior indicate that the slurry presented the structure similar to viscoelastic body and the property of shear thinning at the beginning. During the setting process, the slurry was transformed from a flocculent structure to a net structure, and the strength increased. Different factors had diverse effects on the rheological properties of the CPC slurry in the setting process, a reflection of the flowing properties (or injection), and the microstructure development of this concentrated suspension. Raising the powder-to-liquid ratio decreased the distance among the particles, increased the initial strength, and shortened the setting time. In addition, raising the temperature improved the initial strength, increased the order of reaction, and shortened the setting time, which was favorable to the setting process. The particle size of the raw material had much to do with the strength of original structure and setting time. The storage module G' of CPC slurry during the setting process followed the rule of power law function G'=A exp(Bt), which could be applied to forecast the setting time, and the calculated results thereafter are in agreement with the experimental data.